- Home
- LITB vs TARA Comparison
LITB vs TARA Comparison
Compare LITB & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITB
- TARA
- Stock Information
- Founded
- LITB 2007
- TARA N/A
- Country
- LITB Singapore
- TARA United States
- Employees
- LITB N/A
- TARA N/A
- Industry
- LITB Catalog/Specialty Distribution
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LITB Consumer Discretionary
- TARA Health Care
- Exchange
- LITB Nasdaq
- TARA Nasdaq
- Market Cap
- LITB 68.2M
- TARA 39.6M
- IPO Year
- LITB N/A
- TARA N/A
- Fundamental
- Price
- LITB $2.35
- TARA $1.85
- Analyst Decision
- LITB
- TARA Strong Buy
- Analyst Count
- LITB 0
- TARA 2
- Target Price
- LITB N/A
- TARA $24.00
- AVG Volume (30 Days)
- LITB 14.3K
- TARA 119.0K
- Earning Date
- LITB 11-26-2024
- TARA 11-01-2024
- Dividend Yield
- LITB N/A
- TARA N/A
- EPS Growth
- LITB N/A
- TARA N/A
- EPS
- LITB N/A
- TARA N/A
- Revenue
- LITB $430,411,000.00
- TARA N/A
- Revenue This Year
- LITB N/A
- TARA N/A
- Revenue Next Year
- LITB N/A
- TARA N/A
- P/E Ratio
- LITB N/A
- TARA N/A
- Revenue Growth
- LITB N/A
- TARA N/A
- 52 Week Low
- LITB $2.21
- TARA $1.04
- 52 Week High
- LITB $8.10
- TARA $5.24
- Technical
- Relative Strength Index (RSI)
- LITB 39.26
- TARA 52.07
- Support Level
- LITB $2.33
- TARA $1.60
- Resistance Level
- LITB $2.80
- TARA $1.85
- Average True Range (ATR)
- LITB 0.27
- TARA 0.13
- MACD
- LITB -0.01
- TARA 0.02
- Stochastic Oscillator
- LITB 14.67
- TARA 52.58
About LITB LightInTheBox Holding Co. Ltd.
LightInTheBox Holding Co Ltd is an online retail company delivering products directly to consumers across the world. It provides apparel products including customized, special occasion and fast fashion apparel products; and other general merchandise products, such as accessories and gadgets, home and garden products, electronics and communication devices, and other products. The company is engaged in product sales which consisted of online retailing of consumer products. It also provides services which consisted of the provision of logistic services to e-commerce retailers and small businesses. Geographically, it operates in Europe which is the key revenue driver, North America, and other countries.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).